105 related articles for article (PubMed ID: 32233607)
1. Long noncoding RNA MIR22HG is down-regulated in prostate cancer.
Shen H; Weng XD; Yang D; Wang L; Liu XH
Math Biosci Eng; 2019 Dec; 17(2):1776-1786. PubMed ID: 32233607
[TBL] [Abstract][Full Text] [Related]
2. Identification of Long Noncoding RNA MIR22HG as a Novel Biomarker in Thyroid Cancer.
Qin L; Luo JZ; Tang XL; Han CG
Pathol Oncol Res; 2019 Apr; 25(2):703-710. PubMed ID: 30539522
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.
Li H; Wang Y
Med Sci Monit; 2019 Jan; 25():656-665. PubMed ID: 30670679
[TBL] [Abstract][Full Text] [Related]
5. Silencing of Long Noncoding RNA
Su W; Feng S; Chen X; Yang X; Mao R; Guo C; Wang Z; Thomas DG; Lin J; Reddy RM; Orringer MB; Chang AC; Yang Z; Beer DG; Chen G
Cancer Res; 2018 Jun; 78(12):3207-3219. PubMed ID: 29669758
[TBL] [Abstract][Full Text] [Related]
6. Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers.
Zhang L; Li C; Su X
J Exp Clin Cancer Res; 2020 Dec; 39(1):271. PubMed ID: 33267888
[TBL] [Abstract][Full Text] [Related]
7. LncRNA
Su W; Guo C; Wang L; Wang Z; Yang X; Niu F; Tzou D; Yang X; Huang X; Wu J; Chen X; Zou L; Yang Z; Chen G
Aging (Albany NY); 2019 Jul; 11(13):4587-4596. PubMed ID: 31291201
[TBL] [Abstract][Full Text] [Related]
8. Identification and Functional Characterization of Long Non-coding RNA
Zhang DY; Zou XJ; Cao CH; Zhang T; Lei L; Qi XL; Liu L; Wu DH
Theranostics; 2018; 8(14):3751-3765. PubMed ID: 30083257
[TBL] [Abstract][Full Text] [Related]
9. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells.
Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L
Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848
[TBL] [Abstract][Full Text] [Related]
11. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation.
Cui Z; An X; Li J; Liu Q; Liu W
Biomed Pharmacother; 2018 Aug; 104():223-228. PubMed ID: 29775889
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
14. MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation.
Tang Q; Jiang X; Ma S; Wang L; Li R; Ma J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32500915
[TBL] [Abstract][Full Text] [Related]
15. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.
Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway.
Long H; Li Q; Xiao Z; Yang B
Bioengineered; 2021 Dec; 12(1):3148-3158. PubMed ID: 34187303
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
Guo Z; He C; Yang F; Qin L; Lu X; Wu J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the long noncoding RNA MIR22HG as a tumour suppressor in cervical cancer by targeting IGF2BP2.
Shu J; Wang D
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7953-7962. PubMed ID: 32767321
[TBL] [Abstract][Full Text] [Related]
19. TUG1 promotes the development of prostate cancer by regulating RLIM.
Guo BH; Zhao Q; Li HY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
[TBL] [Abstract][Full Text] [Related]
20. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
